Zinbryta FAQ
What is Zinbryta
Who makes Zinbryta?
When was Zinbryta approved?
Why was Zinbryta withdrawn from the market?
Which serious side effects has Zinbryta been linked to?
Are there other health effects linked to Zinbryta?
Is there a difference between a recall and a withdrawal?
Are Zinbryta lawsuits currently being filed?
Is there a Zinbryta class action?
What is Zinbryta?
Zinbryta (generic: daclizumab) is used to treat relapsing forms of multiple sclerosis (MS). The drug is classified as a monoclonal antibody, and works by affecting actions of the body’s immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body, which may help to protect healthy cells from damage.
Who makes Zinbryta?
Zinbryta is developed in a joint partnership between AbbVie and BioGen Inc.
When was Zinbryta Aapproved?
The U.S. Food & Drug Administration (FDA) approved Zinbryta for the treatment of of adults with relapsing forms of multiple sclerosis on May 27, 2016.
Why was Zinbryta withdrawn from the market?
AbbVie and BioGen announced that they withdrew Zinbryta from the global market on March 2, 2018, after reports surfaced of patients suffering extreme brain inflammation and even dying while being treated with the drug.
Which serious side effects has Zinbryta been linked to?
- Liver failure
- Drug-induced hepatitis
- Inflammatory encephalitis
- Menigeoncephalitis
- Death
Are there other health effects linked to Zinbryta?
Yes. In addition to causing the above serious side effects, Zinbryta has been linked to a host of more moderate side effects, including:
- Runny or stuffy nose
- Upper respiratory tract infection
- Rash, including drug rash
- Influenza
- Skin rash
- Mouth pain
- Sore throat
- Bronchitis
- Eczema
- Swollen lymph nodes
- Depression
- Increased alanine aminotransferase (ALT)
- Acne
- Anemia
- Fever
Is there a difference between a recall and a withdrawal?
Yes. A product recall removes products from distribution, sale or consumption that present a significant health or safety threat because of a product defect or contamination. A product withdrawal, on the other hand, is where product is removed from the supply chain as a precautionary measure, pending investigation into a potential safety risk.
Are Zinbryta lawsuits currently being filed?
Yes. Our lawyers are currently filing lawsuits on behalf of people who suffered one or more of the following serious side effects after taking Zinbryta:
- Liver failure
- Drug-induced hepatitis
- Inflammatory encephalitis
- Menigeoncephalitis
- Death
Is there a Zinbryta class action?
No class action lawsuit has been filed in the Zinbryta litigation. The drug was only on the market less than 2 years, and it typically takes much longer than that for enough complaints about a medication to accumulate to justify class action status. However, that doesn’t mean you’re out of luck if you’ve been injured. Our lawyers are currently filing individual lawsuits on behalf of people who were severely injured or died while taking Zinbryta.